Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Stephanie P. Saw"'
Autor:
Stephanie P.L. Saw, MRCP, Gek San Tan, MSc, Wei Chong Tan, MRCP, Aaron C. Tan, PhD, Gillianne G.Y. Lai, MRCP, Darren W.T. Lim, MRCP, Ravindran Kanesvaran, MRCP, Wan Ling Tan, MRCP, Sze Huey Tan, PhD, Kiat Hon Lim, FRCPA, Anders J. Skanderup, PhD, Daniel S.W. Tan, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100599- (2023)
Introduction: To compare the performance of droplet digital polymerase chain reaction (ddPCR) and plasma next-generation sequencing (NGS) in detecting clearance of plasma EGFR (pEGFR) mutations. Methods: Patients with treatment-naive advanced EGFR-mu
Externí odkaz:
https://doaj.org/article/95ba3defcb024f6c832156416fd09357
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC
Autor:
Gillianne G.Y. Lai, MBBS, Jia Chi Yeo, PhD, Amit Jain, MBBS, PhD, Siqin Zhou, MSc, Mengyuan Pang, MSc, Jacob J.S. Alvarez, BSc, Ngak Leng Sim, BCS, Aaron C. Tan, MBBS, FRACP, PhD, Lisda Suteja, BSc, Tze Wei Lim, BSc, Yu Amanda Guo, PhD, Meixin Shen, PhD, Stephanie P.L. Saw, MBBS, Neha Rohatgi, BSc, Joe P.S. Yeong, MBBS, PhD, Angela Takano, MBBS, Kiat Hon Lim, MBBS, Apoorva Gogna, MBBS, Chow Wei Too, MBBS, Kun Da Zhuang, MBBS, Wan Ling Tan, MBBS, Ravindran Kanesvaran, MBBS, Quan Sing Ng, MBBS, Mei Kim Ang, MBBS, Tanujaa Rajasekaran, MBBS, Lanying Wang, MBBS, Chee Keong Toh, MBBS, Wan-Teck Lim, MBBS, Wai Leong Tam, PhD, Sze Huey Tan, PhD, Anders M.J. Skanderup, PhD, Eng-Huat Tan, MBBS, Daniel S.W. Tan, BSc, MBBS, MRCP, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 12, Pp 100416- (2022)
Introduction: Although immune checkpoint inhibitors (ICIs) have dramatically improved outcomes for nononcogene-addicted NSCLC, monotherapy with programmed cell death protein-1 (PD1) inhibition has been associated with low efficacy in the EGFR-mutant
Externí odkaz:
https://doaj.org/article/7d3ef7d52e0641cbadf717aeaf522b4b
Autor:
Aaron C. Tan, Stephanie P. Saw, Gillianne G. Lai, Kevin L. Chua, Angela Takano, Boon-Hean Ong, Tina P. Koh, Amit Jain, Wan Ling Tan, Quan Sing Ng, Ravindran Kanesvaran, Tanujaa Rajasekaran, Sunil Deochand, Dillon Maloney, Danielle Afterman, Tomer Lauterman, Noah Friedman, Imane Bourzgui, Nidhi Ramaraj, Zohar Donenhirsh, Ronel Veksler, Jonathan Rosenfeld, Ravi Kandasamy, Iman Tavassoly, Boris Oklander, Asaf Zviran, Wan-Teck Lim, Eng-Huat Tan, Anders J. Skanderup, Mei-Kim Ang, Daniel S. Tan
Publikováno v:
Cancer Research. 82:5114-5114
Background: Early detection of recurrence and monitoring of MRD post-surgery is critical for clinical decision-making to tailor adjuvant therapy. In early-stage NSCLC, circulating tumor DNA (ctDNA) detection is especially challenging, requiring highl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b5a6654920087558099b164d7fc446d
https://doi.org/10.1158/1538-7445.am2022-5114
https://doi.org/10.1158/1538-7445.am2022-5114